Sign up to save your podcasts
Or
Share A closer look at pharma's top R&D budgets
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A closer look at pharma's top R&D budgets
In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent special report from Fierce Biotech, ranking the top 10 R&D budgets from 2024.
Did Merck hold on to its 2023 crown? And did any new faces crack this year’s list? Listen to find out!
To learn more about the topics in this episode:
- The top 10 pharma R&D budgets for 2024
This week's episode is brought to you by Cencora.
See omnystudio.com/listener for privacy information.
View all episodes
By Fierce Life Sciences
4
1111 ratings
In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent special report from Fierce Biotech, ranking the top 10 R&D budgets from 2024.
Did Merck hold on to its 2023 crown? And did any new faces crack this year’s list? Listen to find out!
To learn more about the topics in this episode:
- The top 10 pharma R&D budgets for 2024
This week's episode is brought to you by Cencora.
See omnystudio.com/listener for privacy information.
More shows like The Top Line
View all
Planet Money
30,811 Listeners
Motley Fool Money
3,221 Listeners
Exchanges
951 Listeners
Odd Lots
1,964 Listeners
WSJ Tech News Briefing
1,650 Listeners
The a16z Show
1,093 Listeners
The Readout Loud
323 Listeners
Wall Street Breakfast
1,045 Listeners
Behind the Money
227 Listeners
The Journal.
6,068 Listeners
BioCentury This Week
34 Listeners
Economics Explained
151 Listeners
Biotech Hangout
21 Listeners
The Markets
79 Listeners
WSJ's Take On the Week
142 Listeners